Johnson & Johnson Current Ratio 2006-2018 | JNJ

Historical current ratio values for Johnson & Johnson (JNJ) over the last 10 years.
Johnson & Johnson Annual Current Ratio
2017 1.41
2016 2.47
2015 2.17
2014 2.23
2013 2.20
2012 1.90
2011 2.38
2010 2.05
2009 1.82
2008 1.65
2007 1.51
2006 1.20
2005 2.49
Johnson & Johnson Quarterly Current Ratio
Q2 2018 1.65
Q1 2018 1.58
Q4 2017 1.41
Q3 2017 1.32
Q2 2017 1.34
Q1 2017 2.52
Q4 2016 2.47
Q3 2016 2.73
Q2 2016 3.08
Q1 2016 2.84
Q4 2015 2.17
Q3 2015 2.51
Q2 2015 2.49
Q1 2015 2.44
Q4 2014 2.23
Q3 2014 2.61
Q2 2014 2.47
Q1 2014 2.41
Q4 2013 2.20
Q3 2013 2.02
Q2 2013 2.16
Q1 2013 2.10
Q4 2012 1.90
Q3 2012 1.87
Q2 2012 1.75
Q1 2012 2.69
Q4 2011 2.38
Q3 2011 2.46
Q2 2011 2.51
Q1 2011 2.05
Q4 2010 2.05
Q3 2010 2.45
Q2 2010 2.27
Q1 2010 2.10
Q4 2009 1.82
Q3 2009 1.85
Q2 2009 1.79
Q1 2009 1.63
Q4 2008 1.65
Q3 2008 1.61
Q2 2008 1.65
Q1 2008 1.53
Q4 2007 1.51
Q3 2007 1.50
Q2 2007 1.36
Q1 2007 1.26
Q4 2006 1.20
Q3 2006 2.59
Q2 2006 2.59
Q1 2006 2.56
Q4 2005 2.49
Q3 2005 2.54
Q2 2005 2.47
Q1 2005 2.22
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $350.789B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $243.651B 14.26
Novartis AG (NVS) Switzerland $190.263B 16.32
Merck (MRK) United States $178.137B 15.73
AbbVie (ABBV) United States $145.067B 14.17
Novo Nordisk (NVO) Denmark $114.528B 18.31
Eli Lilly (LLY) United States $109.815B 20.33
Sanofi (SNY) France $104.261B 13.20
AstraZeneca (AZN) United Kingdom $99.745B 10.97
GlaxoSmithKline (GSK) United Kingdom $99.569B 13.30
Bristol-Myers Squibb (BMY) United States $96.944B 17.55